Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
24,701,460
-
Number of holders
-
231
-
Total 13F shares, excl. options
-
22,697,462
-
Shares change
-
+422,777
-
Total reported value, excl. options
-
$3,743,979,121
-
Value change
-
+$70,541,615
-
Put/Call ratio
-
28%
-
Number of buys
-
104
-
Number of sells
-
-102
-
Price
-
$164.96
Significant Holders of ICU MEDICAL INC/DE - Common Stock (ICUI) as of Q1 2023
270 filings reported holding ICUI - ICU MEDICAL INC/DE - Common Stock as of Q1 2023.
ICU MEDICAL INC/DE - Common Stock (ICUI) has 231 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22,697,462 shares
of 24,701,460 outstanding shares and own 92% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (2,560,869 shares), T. Rowe Price Investment Management, Inc. (2,419,364 shares), WELLINGTON MANAGEMENT GROUP LLP (2,206,384 shares), VANGUARD GROUP INC (2,134,038 shares), BlackRock Inc. (1,751,044 shares), JPMORGAN CHASE & CO (779,705 shares), MORGAN STANLEY (690,991 shares), FULLER & THALER ASSET MANAGEMENT, INC. (670,343 shares), STATE STREET CORP (615,129 shares), and VICTORY CAPITAL MANAGEMENT INC (597,877 shares).
This table shows the top 231 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.